Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma
暂无分享，去创建一个
D. Schadendorf | P. Ascierto | E. Lipson | H. Tawbi | H. Gogas | J. Grob | P. Rutkowski | G. Long | S. Dalle | S. Dolfi | P. Salman | C. Lao | F. Stephen Hodi | A. Arance | S. Keidel | L. Matamala | Erika Castillo Gutiérrez | A.M. Sobiesk | Juliana Janoski de Menezes | Anadil Shaikh